Age-Related Macular Degeneration (AMD) Treatment in Red Bank, NJ

Age-related macular degeneration is a leading cause of central vision loss in adults over 50. At Crystal Eyecare in Red Bank, New Jersey, we provide thorough evaluations, education, and coordinated care to help you understand AMD, monitor changes, and access appropriate treatment with our ophthalmology partners when needed.

Book an AMD Evaluation or call 732-615-9300.

What Is AMD?

AMD affects the macula, the area of the retina that provides sharp, straight-ahead vision. It has two main forms. Dry AMD involves gradual changes in the macula. Wet (neovascular) AMD involves abnormal blood vessels that can leak and scar, which may cause faster vision loss.

Common Symptoms

Blurred or fuzzy central vision
Distortion of straight lines
Dark or empty spots in central vision
Difficulty reading, recognizing faces, or seeing fine detail

Risk Factors

Age over 50
Family history or genetic factors
Cigarette smoking
Cardiometabolic factors such as hypertension or elevated cholesterol

How We Diagnose and Monitor

Your visit may include a dilated retinal exam, retinal imaging, visual function testing, and discussion of risk factors and lifestyle. We educate you on signs that require prompt attention. We coordinate referrals for treatments such as intravitreal anti-VEGF injections when indicated for neovascular AMD.

Evidence-Based Treatment Overview

AREDS2 nutritional formula for intermediate AMD: For patients who meet clinical criteria, the AREDS2 formula can reduce the risk of progression to advanced AMD. Your provider will advise if this is appropriate and will avoid beta-carotene in current or former smokers.
Anti-VEGF therapy for wet AMD: Intravitreal medications can stabilize or improve vision for many patients with neovascular AMD. Treatment schedules vary by drug and clinical response.
Lifestyle support: Smoking cessation, a balanced diet rich in leafy greens and fish, regular exercise, and control of blood pressure and cholesterol support overall eye health.
Home monitoring: Report new distortion or a sudden change in central vision promptly. Traditional Amsler grids can be used, although their sensitivity is limited. Seek clinical evaluation if you notice any change.

Our Role in Your Care

Crystal Eyecare provides comprehensive evaluations, education, and ongoing monitoring. When specialist treatment is needed, we coordinate care with trusted retinal physicians and continue local follow-up to help protect your vision.

References (NIH/NEI and PubMed)

National Eye Institute. Age-Related Macular Degeneration (AMD). nei.nih.gov/…/age-related-macular-degeneration
National Eye Institute. AREDS/AREDS2 Clinical Trials. nei.nih.gov/…/about-areds-and-areds2
AREDS2 Research Group. JAMA 2013;309(19):2005-2015. pubmed.ncbi.nlm.nih.gov/23644932/
Chew EY, et al. Ten-year AREDS2 follow-up. JAMA Ophthalmology 2022;140(6):521-528. jamanetwork.com/…/2792855
CATT Research Group. Ranibizumab vs bevacizumab for neovascular AMD, 1-year results. NEJM 2011;364:1897-1908. pubmed.ncbi.nlm.nih.gov/21526923/
CATT Research Group. Two-year results. Ophthalmology 2012;119(7):1388-1398. pubmed.ncbi.nlm.nih.gov/22555112/
Velilla S, et al. Smoking and AMD review. Arch Soc Esp Oftalmol 2013;88(3):100-113. pmc.ncbi.nlm.nih.gov/articles/PMC3866712/
Bjerager J, et al. Diagnostic accuracy of the Amsler grid for neovascular AMD. Ophthalmology Retina 2023;7(9):810-819. pubmed.ncbi.nlm.nih.gov/36795396/